Vivos Therapeutics, Inc. (NASDAQ:VVOS)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Loses money on what it sells.
- Revenue
- $20.9M
- Net income
- -$25.6M
- Net margin
- -122.4%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $12.1M
- Cash
- $1.8M
Owes more within a year than it holds to pay it.
- Current assets
- $4.2M
- Current liabilities
- $20.4M
- Current ratio
- 0.21
Consumes cash and must keep raising it.
- Operating cash flow
- -$17.1M
- Free cash flow
- -$17.9M
- FCF margin
- -85.8%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 17.7M
- Share growth (1y)
- 94.6%
- Cash runway
- 1 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
VVOS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 5.15 M | 5.14 M | 3.82 M | 6.78 M | 3.82 M | 3.02 M |
| Revenue Growth (YoY) | 34.90 % | 70.46 % | 3.41 % | 75.73 % | -5.77 % | -11.79 % |
| Cost of Revenue | 2.20 M | 2.54 M | 836.00 K | 2.85 M | 1.71 M | 1.51 M |
| Gross Profit | 2.95 M | 2.60 M | 2.99 M | 3.94 M | 2.11 M | 1.51 M |
| SG&A Expense | 7.27 M | 9.22 M | 8.93 M | 8.29 M | 6.67 M | 5.25 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.78 M | 9.22 M | 9.37 M | 8.67 M | 6.97 M | 5.43 M |
| Operating Income | -4.83 M | -6.62 M | -6.38 M | -4.73 M | -4.87 M | -3.92 M |
| Pretax Income | -5.52 M | -7.75 M | -6.95 M | -5.40 M | -5.01 M | -3.86 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -5.48 M | -7.75 M | -6.95 M | -5.40 M | -5.01 M | -3.86 M |
| EPS (Basic) | -0.31 | -0.52 | -0.74 | -0.49 | -0.55 | -0.45 |
| EPS (Diluted) | -0.31 | -0.52 | -0.74 | -0.49 | -0.55 | -0.45 |
| Shares Outstanding | 17.68 M | 14.63 M | 9.29 M | 10.96 M | 9.09 M | 8.60 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.